F8IL10

DRUG4 trials

Sponsors

Philogen S.p.A.

Conditions

Rheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 1

Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients

CompletedNCT02076659

Philogen S.p.A.Rheumatoid Arthritis

Start: 2011-09-30End: 2017-04-13Updated: 2018-05-18

Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment

WithdrawnNCT05622175

Philogen S.p.A.Rheumatoid Arthritis

Start: 2023-03-31End: 2026-12-31Updated: 2025-12-02

A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis

RecruitingNCT07245992

Philogen S.p.A.Rheumatoid Arthritis (RA)

Start: 2026-03-04End: 2029-09-30Target: 42Updated: 2026-08-11

Phase 2

A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX

TerminatedNCT02270632

Philogen S.p.A.Rheumatoid Arthritis

Start: 2014-10-01End: 2023-06-08Updated: 2023-06-12